Project Grant HT94252410633
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$125K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The University of New South Wales (UNSW) was awarded a $2,059,003.85 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, the funding will enable UNSW to conduct research aimed at understanding and overcoming resistance to new and emerging therapies in...
The U.S. Defense Health Agency awarded a $437,975 Project Grant to the University of New South Wales, doing business as The University of NSW, to conduct research on "TARGETING THE NOVEL LONG NONCODING RNA PRKCQ-AS1 FOR CANCER THERAPY". This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for U.S. Service Members and the public. The funded research aims...
The U.S. Defense Health Agency has awarded a $367,622 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to St. Vincent's Institute of Medical Research, a foreign-owned non-profit organization based in Australia. The grant supports a 2-year research project focused on studying the reprogramming of mRNA translation as a driver of drug resistance in ovarian cancer. The research aims to transform healthcare for military service members and the broader public...
The University of Melbourne was awarded a $369,855.64 Project Grant from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to conduct research on "Piecing the Puzzle Together: Unraveling the Genomic Landscape of Low-Grade Serous Ovarian Carcinoma (LGSOC) to Guide Novel Therapeutic Strategies." This 2-year grant, running from Sep 1, 2023 to Aug 31, 2025, will support the university's efforts to advance the understanding of low-grade...
This federal Project Grant award in the amount of $1,439,093.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of New Mexico Health Sciences Center (UNM HSC). The grant will support advancing clinical research on ovarian cancer over a performance period from June 1, 2024 to May 31, 2028. As part of this award, UNM HSC will leverage its expertise in cancer research, genomics, and clinical trials to conduct...
This $1,072,784 federal Project Grant was awarded on May 1, 2024 by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to the University of Melbourne (Australia) to conduct research aimed at "IMPROVING OVARIAN CANCER OUTCOMES BY UNDERSTANDING AND TARGETING ACQUIRED RESISTANCE." The research project is scheduled for completion on April 30, 2028. The University of Melbourne has a history of successfully delivering...
The U.S. Defense Health Agency awarded a $577,680 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Regents of the University of Colorado, doing business as the University of Colorado. The funding supports a 4-year research project titled "Targeting EHMT1/2 to Overcome Therapy-Resistant Ovarian Cancer" that aims to develop innovative approaches to prevent, diagnose, and treat ovarian cancer, a disease highly relevant to...
The University of Sydney was awarded a $919,739 Project Grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund a molecular epidemiological study from September 2021 through September 2025 examining the relationship between aspirin and NSAID use and ovarian cancer prognosis. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
This federal Project Grant award of $5,835,803.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development of a Breast Cancer Cellular Atlas at the University of New South Wales (UNSW) in Australia. The award, which commenced on March 1, 2025, supports advanced biomedical research to transform healthcare for military service members and the broader public. UNSW, as a prominent Australian research institution with expertise...
The U.S. Department of Defense's Defense Health Agency has awarded a $466,234 Project Grant to the University of Queensland in Australia to conduct "PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC." This research grant, funded through the Military Medical Research and Development program (CFDA 12.420), aims to develop innovative treatments and diagnostic tools to improve care for military service members, veterans, and their...